These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 37964635

  • 1. MMPP is a novel VEGFR2 inhibitor that suppresses angiogenesis via VEGFR2/AKT/ERK/NF-κB pathway.
    Kim NY, Park HM, Park JY, Kim U, Shin HY, Lee HP, Hong JT, Yoon DY.
    BMB Rep; 2024 May; 57(5):244-249. PubMed ID: 37964635
    [Abstract] [Full Text] [Related]

  • 2. Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.
    Dong F, Zhou X, Li C, Yan S, Deng X, Cao Z, Li L, Tang B, Allen TD, Liu J.
    Cancer Biol Ther; 2014 May; 15(11):1479-88. PubMed ID: 25482945
    [Abstract] [Full Text] [Related]

  • 3. Activating CD137 Signaling Promotes Sprouting Angiogenesis via Increased VEGFA Secretion and the VEGFR2/Akt/eNOS Pathway.
    Li B, Zhang Y, Yin R, Zhong W, Chen R, Yan J.
    Mediators Inflamm; 2020 May; 2020():1649453. PubMed ID: 33162828
    [Abstract] [Full Text] [Related]

  • 4. Oroxyloside inhibits angiogenesis through suppressing internalization of VEGFR2/Flk-1 in endothelial cells.
    Zhao K, Li X, Lin B, Yang D, Zhou Y, Li Z, Guo Q, Lu N.
    J Cell Physiol; 2018 Apr; 233(4):3454-3464. PubMed ID: 28926106
    [Abstract] [Full Text] [Related]

  • 5. Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways.
    Zhang L, Ji Q, Liu X, Chen X, Chen Z, Qiu Y, Sun J, Cai J, Zhu H, Li Q.
    Cancer Sci; 2013 May; 104(5):604-10. PubMed ID: 23363445
    [Abstract] [Full Text] [Related]

  • 6. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
    Omar HA, Arafa el-SA, Salama SA, Arab HH, Wu CH, Weng JR.
    Toxicol Appl Pharmacol; 2013 Nov 01; 272(3):616-24. PubMed ID: 23921148
    [Abstract] [Full Text] [Related]

  • 7. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
    Niu G, Sun L, Pei Y, Wang D.
    Anticancer Agents Med Chem; 2018 Nov 01; 18(4):583-590. PubMed ID: 29065844
    [Abstract] [Full Text] [Related]

  • 8. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X, Wu L, Zhou X, Zhou N, Zhuang Q, Yang J, Dai J, Wang H, Chen S, Mao W.
    Microvasc Res; 2017 May 01; 111():25-31. PubMed ID: 28040437
    [Abstract] [Full Text] [Related]

  • 9. α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway.
    Saraswati S, Kumar S, Alhaider AA.
    Mol Cancer; 2013 Nov 22; 12():147. PubMed ID: 24261856
    [Abstract] [Full Text] [Related]

  • 10. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW, Lien JC, Kuo SC, Huang TF.
    Carcinogenesis; 2012 May 22; 33(5):1022-30. PubMed ID: 22436611
    [Abstract] [Full Text] [Related]

  • 11. Jaceosidin, a natural flavone, promotes angiogenesis via activation of VEGFR2/FAK/PI3K/AKT/NF-κB signaling pathways in endothelial cells.
    Lee TH, Jung H, Park KH, Bang MH, Baek NI, Kim J.
    Exp Biol Med (Maywood); 2014 Oct 22; 239(10):1325-34. PubMed ID: 24939823
    [Abstract] [Full Text] [Related]

  • 12. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
    Sadremomtaz A, Mansouri K, Alemzadeh G, Safa M, Rastaghi AE, Asghari SM.
    Biochim Biophys Acta Gen Subj; 2018 Dec 22; 1862(12):2688-2700. PubMed ID: 30251659
    [Abstract] [Full Text] [Related]

  • 13. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
    Bi YL, Mi PY, Zhao SJ, Pan HM, Li HJ, Liu F, Shao LR, Zhang HF, Zhang P, Jiang SL.
    Int J Mol Med; 2017 May 22; 39(5):1255-1261. PubMed ID: 28358414
    [Abstract] [Full Text] [Related]

  • 14. PPemd26, an anthraquinone derivative, suppresses angiogenesis via inhibiting VEGFR2 signalling.
    Huang SW, Lien JC, Kuo SC, Huang TF.
    Br J Pharmacol; 2014 Dec 22; 171(24):5728-42. PubMed ID: 25091695
    [Abstract] [Full Text] [Related]

  • 15. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
    Lim HN, Jang JP, Han JM, Jang JH, Ahn JS, Jung HJ.
    Molecules; 2018 Mar 02; 23(3):. PubMed ID: 29498688
    [Abstract] [Full Text] [Related]

  • 16. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Saraswati S, Kanaujia PK, Kumar S, Kumar R, Alhaider AA.
    Mol Cancer; 2013 Jul 29; 12():82. PubMed ID: 23895055
    [Abstract] [Full Text] [Related]

  • 17. Quercetin-4'-O-β-D-glucopyranoside (QODG) inhibits angiogenesis by suppressing VEGFR2-mediated signaling in zebrafish and endothelial cells.
    Lin C, Wu M, Dong J.
    PLoS One; 2012 Jul 29; 7(2):e31708. PubMed ID: 22348123
    [Abstract] [Full Text] [Related]

  • 18. Deltonin inhibits angiogenesis by regulating VEGFR2 and subsequent signaling pathways in endothelial cells.
    Tong Q, Zhao Q, Qing Y, Hu X, Jiang L, Wu X.
    Steroids; 2015 Apr 29; 96():30-6. PubMed ID: 25554580
    [Abstract] [Full Text] [Related]

  • 19. E7050 Suppresses the Growth of Multidrug-Resistant Human Uterine Sarcoma by Inhibiting Angiogenesis via Targeting of VEGFR2-Mediated Signaling Pathways.
    Huang TT, Chen CM, Lin SS, Lan YW, Cheng HC, Choo KB, Wang CC, Huang TH, Chong KY.
    Int J Mol Sci; 2023 May 31; 24(11):. PubMed ID: 37298555
    [Abstract] [Full Text] [Related]

  • 20. Ethyl cinnamate suppresses tumor growth through anti-angiogenesis by attenuating VEGFR2 signal pathway in colorectal cancer.
    Wang S, Yang J, Kuang X, Li H, Du H, Wu Y, Xu F, Liu B.
    J Ethnopharmacol; 2024 May 23; 326():117913. PubMed ID: 38360380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.